Multiple Sclerosis Drugs Market is expected to reach USD 37.69 billion by 2028, at a CAGR of 4.6%.

North American region is anticipated to have the highest share of the multiple sclerosis drug market in the forecast period due to the growing awareness of the multiple sclerosis treatment in this region

Spread the love

Global Multiple Sclerosis Drugs Market was valued at USD 27.51 billion in 2021 and is expected to reach USD 37.69 billion by the year 2028, at a CAGR of 4.6%.

Multiple sclerosis (MS) is a chronic neurological disease caused by an unknown inflammatory process in the central nervous system (CNS), resulting in multifocal demyelination and axonal loss primarily in the white matter but also in the grey matter of both the brain and the spinal cord.

Multiple Sclerosis Drugs market research includes a thorough competitor study analysis and SWOT analysis. According to the market study, report covers key players market share and global impression through collaborations, mergers and acquisitions, joint ventures, partnerships, agreements and product launches. The research examines macroeconomic and microeconomic variables that may affect market demand and growth. The research reports covers COVID-19 impact on  current market position as well as regional analysis for future growth. The market size, share, production, revenue, production, gross margin, pricing, and market-influencing factors are all covered in research report. The market research report is in-depth examined for the relevant time frame.

Read Complete Research @

Multiple Sclerosis Drugs MarketLeading Key Players:

  • Biogen (Massachusetts, U.S.)
  • Pfizer Inc. (New York, U.S.)
  • F. Hoffmann-La Roche Ltd. (Basel, Switzerland)
  • Novartis AG (Basel, Switzerland)
  • Merck & Co., Inc. (New Jersey, U.S.)
  • Sanofi (Paris, France)
  • Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel)
  • Bristol-Myers Squibb Company (New York, U.S.) and Other Major Players.

Download Sample Copy @

Market Dynamics and Factors:


  • The Rise In Prevalence Of Multiple Sclerosis


  • As High-End Drugs Are Administered Treatment of MS Is Expensive


  • The Rise In Research And Development Of MS Drugs

 Market Segment:

By Drug Class    

  • Immunosuppressants
  • Interferon
  • Others

By Diagnosis     

  • Magnetic resonance imaging (MRI)
  • Blood test
  • Lumbar puncture
  • evoked potential test

By Route of Administrations     

  • Injection
  • Oral
  • Others

By Distribution channels             

  • Online Pharmacy
  • Hospital Pharmacy
  • Retail Pharmacy

 Customized Research @

Market Segment by Region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

Key Industry Development In The Multiple Sclerosis Drugs Market

In April 2022, Roche issued a warning that Russia’s attack on Ukraine is interfering with the development of a new generation of multiple sclerosis (MS) drugs, as the industry has come to rely disproportionately on Eastern Europe for clinical trials.

In August 2020, Novartis launched its U.S. Food and Drug Administration (FDA) approved subcutaneous injection for the treatment of relapsing multiple sclerosis. Kesimpta is the name of that injection (ofatumumab).

In January 2020, Bristol Myers Squibb will launch Zeposia. This is one of the more affordable drugs available on the market for people suffering from multiple sclerosis.

 Download Sample Copy @

Key Benefits of Global Market Research Report:

  • Market Segmented by Types, Applications, Regions, and key players
  • Potential Market Drivers. restraints, opportunities and challenges in the study
  • Recent Key industry news, developments and trends
  • Leading Competitive landscape & strategies of industry players
  • Research coves market historical, current, and projected market size and share value
  • In-depth analysis of market in terms of sales, price, revenue, market share, and growth rate
  • Research covers the porter analysis Bargaining Power of Suppliers and consumers, Threats of New Entrants, Substitute Product and Services

About us:

Introspective Market Research ( is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact us:

Introspective Market Research

3001 S King Drive,

Chicago, Illinois

60616 USA

Ph no: +1-773-382-1047

LinkedIn | Twitter | Facebook

Spread the love

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button